{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["65(11)"],"submitter":["Zaidan N"],"pubmed_abstract":["Extremely drug-resistant (XDR) Acinetobacter baumannii causes challenging nosocomial infections. We report the case of a patient with XDR A. baumannii pneumonia and septic shock successfully treated with cefiderocol and a novel antibiotic obtained via expanded access protocol. With focused research and drug development efforts, the poor outcomes associated with these infections may be mitigated."],"journal":["Antimicrobial agents and chemotherapy"],"pagination":["e0092421"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8522738"],"repository":["biostudies-literature"],"pubmed_title":["Extensively Drug-Resistant Acinetobacter baumannii Nosocomial Pneumonia Successfully Treated with a Novel Antibiotic Combination."],"pmcid":["PMC8522738"],"pubmed_authors":["Zaidan N","Hornak JP","Reynoso D"],"additional_accession":[]},"is_claimable":false,"name":"Extensively Drug-Resistant Acinetobacter baumannii Nosocomial Pneumonia Successfully Treated with a Novel Antibiotic Combination.","description":"Extremely drug-resistant (XDR) Acinetobacter baumannii causes challenging nosocomial infections. We report the case of a patient with XDR A. baumannii pneumonia and septic shock successfully treated with cefiderocol and a novel antibiotic obtained via expanded access protocol. With focused research and drug development efforts, the poor outcomes associated with these infections may be mitigated.","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Oct","modification":"2025-04-19T12:12:41.451Z","creation":"2025-04-19T12:12:41.451Z"},"accession":"S-EPMC8522738","cross_references":{"pubmed":["34370576"],"doi":["10.1128/AAC.00924-21","10.1128/aac.00924-21"]}}